If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hakusyo Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Liver Medicine & Life Sciences
Macrophages Medicine & Life Sciences
Concanavalin A Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Interferons Medicine & Life Sciences
Hepatitis Medicine & Life Sciences
Liver Cirrhosis Medicine & Life Sciences
chronic hepatitis C Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

  • 318 Citations
  • 9 h-Index
  • 19 Article
1 Citation (Scopus)
Indigo Carmine
Ulcerative Colitis
Pulmonary Hypertension
Intussusception
Liver Diseases
17 Citations (Scopus)

Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis

Nakamoto, N., Sasaki, N., Aoki, R., Miyamoto, K., Suda, W., Teratani, T., Suzuki, T., Koda, Y., Cho, H., Taniki, N., Yamaguchi, A., Kanamori, M., Kamada, N., Hattori, M., Ashida, H., Sakamoto, M., Atarashi, K., Narushima, S., Yoshimura, A., Honda, K. & 2 others, Sato, T. & Kanai, T., 2019 Jan 1, (Accepted/In press) In : Nature Microbiology.

Research output: Contribution to journalArticle

Th17 Cells
Sclerosing Cholangitis
Liver Diseases
Microbiota
Bacterial Translocation

Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35

Koda, Y., Nakamoto, N., Chu, P. S., Ugamura, A., Mikami, Y., Teratani, T., Tsujikawa, H., Shiba, S., Taniki, N., Sujino, T., Miyamoto, K., Suzuki, T., Yamaguchi, A., Morikawa, R., Sato, K., Sakamoto, M., Yoshimoto, T. & Kanai, T., 2019 Jul 2, In : The Journal of clinical investigation. 130

Research output: Contribution to journalArticle

Open Access
Dendritic Cells
Liver
Wounds and Injuries
Acute Liver Failure
Immunosuppressive Agents
6 Citations (Scopus)

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

Ji, F., Yeo, Y. H., Wei, M. T., Ogawa, E., Enomoto, M., Lee, D. H., Iio, E., Lubel, J., Wang, W., Wei, B., Ide, T., Preda, C. M., Conti, F., Minami, T., Bielen, R., Sezaki, H., Barone, M., Kolly, P., Cho, H., Virlogeux, V. & 15 others, Eurich, D., Henry, L., Bass, M. B., Kanai, T., Dang, S., Li, Z., Dufour, J. F., Zoulim, F., Andreone, P., Cheung, R. C., Tanaka, Y., Furusyo, N., Toyoda, H., Tamori, A. & Nguyen, M. H., 2019 Jan 1, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Antiviral Agents
Meta-Analysis
Hepatocellular Carcinoma
Therapeutics
2 Citations (Scopus)

Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells

Murakami, Y., Sugiyama, K., Ebinuma, H., Nakamoto, N., Ojiro, K., Cho, H., Taniki, N., Saito, Y., Teratani, T., Koda, Y., Suzuki, T., Saito, K., Fukasawa, M., Ikeda, M., Kato, N., Kanai, T. & Saito, H., 2018 Jun 25, In : BMC Cancer. 18, 1, 680.

Research output: Contribution to journalArticle

NF-E2-Related Factor 2
Liver Neoplasms
Hepacivirus
Hepatocytes
Virus Diseases